Pegrum G D, Williams G, Markwick J, Barnes R M
Postgrad Med J. 1976;52(5 Suppl):47-50.
Survival of Lewis X Brown Norway F1 renal allografts was prolonged in Lewis recipients by pretreatment with small numbers of donor marrow cells and low dose antilymphocyte globulin(ALG)in combination. Either marrow cells or ALG alone were ineffective at these doses. It was also shown that pretreatment with marrow cells and antilymphocyte serum (ALS) considerably suppressed the local graft-versus-host reaction.
在Lewis受体中，通过用少量供体骨髓细胞和低剂量抗淋巴细胞球蛋白（ALG）联合预处理，可延长Lewis X Brown Norway F1肾移植的存活时间。单独使用骨髓细胞或ALG在这些剂量下均无效。还表明，用骨髓细胞和抗淋巴细胞血清（ALS）预处理可显著抑制局部移植物抗宿主反应。
